Hikma Pharmaceutical reported 343M in Operating Profit for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
AstraZeneca AZN:LN -1674000000 2.8B
Bayer BAYN:GR 530M 2.81B
Fresenius FRE:GR € 1008M 13M
Fresenius Medical Care FMS:US $ 505M 80.78M
Galapagos GLPG:NA -78199000 31.45M
Genmab GEN:DC 890M 103M
GlaxoSmithKline GSK:LN 1.94B 263M
GRIFOLS GRF:SM € 250.6M 37.64M
H. Lundbeck A/S LUN:DC 526M 70M
Hikma Pharmaceutical HIK:LN 343M 34M
Lonza Group LONN:SW 317M 34M
Merck MRK:GR € 1047M 2M
Orion ORNBV:FH 57.3M 13.7M
Recordati REC:IM 122.56M 2.92M